0 Comments
0 Shares
300 Views
0 Reviews
Sponsored
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Middle East Cancer Targeted Therapy Market Valued at USD 1.05 Billion in 2024 Strengthened by Advancing Precision Oncology by 2031The Middle East cancer targeted therapy market is witnessing substantial growth due to the increasing prevalence of cancer and the growing adoption of precision medicine across healthcare systems in the region. The Middle East Cancer Targeted Therapy Market size is expected to reach US$ 2,163.7 million by 2031 from US$ 1,051.4 million in 2024. The market is estimated to record a CAGR of 10.9%...0 Comments 0 Shares 429 Views 0 Reviews
-
mTOR Inhibitor Oncology Drug Market Advances with Targeted Cancer Therapy Innovations"Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share Analysis Report CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period mTOR Inhibitor Oncology Drug Market report objective analysis is...0 Comments 0 Shares 714 Views 0 Reviews
-
mTOR Inhibitor Oncology Drug Market Grows with Breakthroughs in Targeted Cancer Therapy"Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share Forecast CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period Competitive analysis performed in this mTOR Inhibitor Oncology Drug Market...0 Comments 0 Shares 860 Views 0 Reviews
-
South and Central America Cancer Targeted Therapy Market Valued at USD 4.73 Billion in 2024 Strengthened by Advancing Precision Oncology by 2031The South and Central America cancer targeted therapy market is expanding rapidly due to the increasing prevalence of cancer and the growing adoption of precision oncology treatments across the region. The South and Central America Cancer Targeted Therapy Market size is expected to reach US$ 10,151.9 million by 2031 from US$ 4,725.4 million in 2024. The market is estimated to record a CAGR of...0 Comments 0 Shares 421 Views 0 Reviews
-
Wnt Pathway Targeted Therapy Market: Industry Outlook & Forecast 2026–2033"According to the latest report published by Data Bridge Market Research, the Wnt Pathway Targeted Therapy Market The global Wnt Pathway Targeted Therapy market size was valued at USD 812.00 Million in 2025 and is expected to reach USD 4198.97 Million by 2033, at a CAGR of 22.80% during the forecast period All the data and information included in the...0 Comments 0 Shares 145 Views 0 Reviews
-
Adult Malignant Glioma Therapeutics Market Report 2031: Growth Drivers, Opportunities, and Competitive StrategiesThe Adult Malignant Glioma Therapeutics Market is experiencing strong growth due to the rising prevalence of aggressive brain tumors and the increasing demand for advanced treatment options. According to insights from The Insight Partners, the Adult Malignant Glioma Therapeutics Market is projected to reach US$ 5.39 billion by 2031, registering a CAGR of 9.8% during 2025–2031. This growth...0 Comments 0 Shares 1K Views 0 Reviews
-
ASEAN Region Witnesses Rapid Shift Toward Targeted Cancer Treatments, Market to 2031 SurgesCancer targeted therapy refers to a treatment approach that uses drugs or biological agents to specifically identify and attack cancer cells while minimizing damage to healthy tissues. The ASEAN Cancer Targeted Therapy Market size is expected to reach US$ 9,217.7 million by 2031 from US$ 3,422.2 million in 2024. The market is estimated to record a CAGR of 15.2% from 2025 to...0 Comments 0 Shares 371 Views 0 Reviews
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Comments 0 Shares 2K Views 0 Reviews
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Comments 0 Shares 1K Views 0 Reviews
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Comments 0 Shares 2K Views 0 Reviews
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Comments 0 Shares 1K Views 0 Reviews
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Comments 0 Shares 1K Views 0 Reviews
-
Global Dual-Antibody ADC Market Growing at 6.2% CAGR Through 2032According to a new report from Intel Market Research, the global Dual-Antibody ADC market was valued at USD 477 million in 2024 and is projected to reach USD 691 million by 2032, exhibiting a steady CAGR of 6.2% during the forecast period (2025–2032). This growth is driven by increasing cancer prevalence and demand for precision medicine, superior tumor targeting capabilities of...0 Comments 0 Shares 543 Views 0 Reviews
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comments 0 Shares 1K Views 0 Reviews
More Results
Sponsored
Sponsored
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek